| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immix Biopharma, Inc. (IMMX) has 9 insiders with recent SEC Form 4 filings, including 12 buys and 1 sell. IMMX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.14M | $11.98M | - | |
| CFO | 291.4K | $3.06M | - | |
| Dir | 39.6K | $415.9K | - | |
| 10% | 33.0K | $346.2K | - | |
| Dir | 33.0K | $346.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2023 | Hsu Jason50 | Director | Buy | 10,000 | $2.53 | $25,317.00 | +1.5% | +91.2% | -24.5% | |
| Sep 7, 2023 | Buchan Melissa Jane51 | Director | Buy | 20,000 | $2.46 | $49,226.00 | New | +96.8% | -20.9% | |
| Sep 6, 2023 | Marquet Magda54 | Director | Buy | 9,000 | $2.47 | $22,212.90 | +81.8% | +105.6% | -16.7% | |
| Sep 5, 2023 | Marquet Magda54 | Director | Buy | 10,000 | $2.47 | $24,722.00 | +1,000% | +105.3% | -17.8% | |
| Aug 31, 2023 | Marquet Magda54 | Director | Buy | 1,000 | $2.01 | $2,010.00 | New | +150.2% | +5.4% | |
| Nov 14, 2022 | Rachman Ilya M64 | CEO And Chairman | Buy | 5,200 | $1.00 | $5,225.45 | +0.2% | +131.1% | +327.2% | |
| Nov 14, 2022 | Morris Gabriel S65 | CFO | Buy | 5,200 | $0.94 | $4,888.00 | +6.8% | +131.1% | +327.2% | |
| Jul 14, 2022 | Senn Sean | 10% Owner | Sell | 200 | $2.75 | $550.00 | - | -55.3% | -13.3% | |
| Dec 20, 2021 | Rachman Ilya M64 | CEO And Chairman | Buy | 2,500 | $5.00 | $12,500.00 | +0.3% | -31.7% | -42.5% | |
| Dec 20, 2021 | Torchilin Vladimir P | Scientific Co-founder | Buy | 5,200 | $4.78 | $24,834.00 | +0.3% | -31.7% | -42.5% |